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Background
Treatment-resistant chronic cluster headache is a debili-
tating disease. Since 2011 we were able to offer cannabis
and we hereby report our experience using cannabis in
this condition.
Methods
A retrospective medical files analysis. The Institutional
Review Board waived the need for informed consent.
Results
Out of 120 patients seen with cluster-headache since 2011,
31 (26%) were diagnosed with chronic cluster-headache.
Eighteen of them (78% men, average age 42.7 ±10 years),
were resistant to conventional treatments for cluster-head-
ache and initiated cannabis treatment. The average dura-
tion of the chronic pain was 8.5 ± 6 years (range 2-28
years). Twelve of the subjects had 1-6, daily or near-daily,
attacks. The rest had 1-4 weekly attacks. Background daily
headache accompanied 7 of the patients.
Smoking was the preferred modality of cannabis usage
(average 1 gram/daily, range 0.7-1.7 grams/daily). In an
average follow-up of 1.8 ± 0.8 years (2 months-3 years),
cannabis usage resulted in >50% decrease of the headache
severity in 15 (83%) patients, and in 90-100% severity
decrease in 11 (61%) subjects. Nine (50%) patients
reported 80-100% decrease in the headache frequency
while the rest had no change in their attack frequency.
Eleven patients (61%) reported high satisfaction from
cannabis usage, with significant reduction of medications;
sleep and quality of life improvement. Somnolence and
dizziness limited cannabis usage in 2 subjects. Treatment
success was unrelated to age, gender, duration of the head-
ache or the chronic state.
Conclusions
Cannabis was found an effective treatment for resistant
chronic cluster-headache, with minimal adverse-events.
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